Impurities in pharmaceuticals

P
P.N.DESHMUKH Lecturer at K.Y.D.S.C.T's college of pharmacy Sakegaon
IMPURITIES IN
PHARMACEUTICALS
Prepared & presented By
Priyanka Deshmukh
K.Y.D.S.C.T’s college of pharmacy, sakegaon
Impurity
 Impurity is the undesirable foreign material
which may be toxic or non toxic present in
the pharmaceutical substance.
 Impurity is the substance or the matter
which does not form a part of the medicinal
or pharmaceutical substance or drugs.
Presentation Title 2
1. Raw materials used in the
manufacturer.
2. Process used in the manufacturer.
3. Material of the plant.
4. Inadequate storage.
5. Accidental substitutions/deliberate
adulteration with spurious/ useless
substance.
6. Manufacturing hazards.
Sources of impurities
1. Raw materials used in
the manufacturer
Traces of raw materials may come in
the final product
e.g.
1. Traces of some sodium compounds
in sodium chloride or the traces of
chloride.may be present in them if not
prepared carefully.
2. Metallic zinc may be present as on
impurity in zinc oxide sample as zinc
oxide can be prepared by heating
metallic zinc(raw materials)
2. Process used in the
manufacture
1. Tap water is invariably used in
various processes. This tap water
contains chloride, calcium &
magnesium, which may contaminate
the substance which is to be
manufactured.
2. Due to the wide use of strong acids in
the manufacture of medicinal
substances chloride & sulphate ions
are very Commonly occuring
impurities. 4
Presentation Title
3. Material of the plant 4. Inadequate storage
1. The equipment or utensils used in the
manufacturing processes are made of
metals like copper, aluminium, iron, zinc,
nickel. & tin or stainless steel.
2. Due to action of the solvents on the
material of the equipment or utensils,
traces of the equipment or utensils, traces
of the metals are introduced as impurities
in the compound
2. Decomposition of the product during
storage
Many chemical substances undergo
changes decomposition due to careless
storage.
a) Due to careless storage, ferrous sulphate
is slowly converted into Insoluble ferric
oxide by air & moisture.
b) Bismuth / carbonate blackens on long
exposure to sunlight.
1. Filth: stored products may become
contaminated with dust, the bodies of
insects and even animal and insect excreta.
Presentation Title
5. Accidental substitutions/deliberate adulteration with spurious/useless
substance
1. Accidental substitution can take place if toxic substances are stocked with other
substances or compound due to incomplete saponification there may be presence
of alkali impurities.
2. Deliberate adulteration or substitution with cheaper drugs or varities is a
possibility.
e.g.
a) Asafoetida can be adulterated with wheat, flour stones..
b) In honey, commerical sugar can be an adulterant.
c) Acacia powder can be adulterated with clay
Presentation Title
6. Manufacturing Hazards
i) Particulate Contamination: Accidental inclusion of dirt or glass, porcelain,
metallic or plastic fragments from sieves, granulating, tableting and filling
machines or even from product containers, may come from either bulk material
used in formulation or from improperly cleaned equipment or containers, but is
more likely to be present due to wear and tear of equipment.
ii) Process Errors: Gross errors arising from incomplete solution of a solute in a
liquid preparation should probably be detected readily by normal analytical
control procedures.
iii) Cross Contamination: The handling of powders, granules and tablets in bulk
quantities, frequently create a considerable amount of air-borne dust, which if
not controlled, leads to cross contamination of products, particularly of
steroidal and other synthetic hormones and antibiotics like penicillin.
Presentation Title
6. Manufacturing Hazards
(iv) Microbial Contamination: Liquid
preparations and creams for topical application to
broken skin or mucous membrane are liable to
bacterial, mould and fungal contamination from
the atmosphere.
(v) Packing Errors: Products of similar
appearance, such as tablets of same size, colour
and shape packed in similar containers can cause
danger through mislabelling.
Effects of impurities in pharmacopoeial substance
The impurities which produce toxic effect on body, if present beyond the prescribed
limit, e.g. Lead and arsenic impurities.
Impurities which are harmless but if present beyond a limit in pharmaceutical substance,
lowers the active strength of that substance. e.g. Impurities of sodium salts in potassium
salts.
Impurities which, if present, beyond the limit, affect the storage capacity of the
pharmaceuticals, e.g., Presence of moisture beyond limit, may activate the free flowing
property of a substance or may decompose it.
Impurities causing technical difficulties, while using the substance, in which it is present.
e.g. Presence of carbonate impurity in the ammonia solution.
Impurities such as taste, odour or colour or appearance which are easily detectable by the
senses and make the substance unaesthetic or unhygienic, e.g. Phenolic impurities
present in sodium salicylate, alter its colour. Traces of magnesium salts in sodium
chloride render it damp and change its appearance
THANK YOU
1 de 10

Recomendados

Osseous System Part I.pptxOsseous System Part I.pptx
Osseous System Part I.pptxSwatiingle7
362 vistas30 diapositivas
Osseous System Part II.pptxOsseous System Part II.pptx
Osseous System Part II.pptxSwatiingle7
138 vistas20 diapositivas
Dental products Dental products
Dental products P.N.DESHMUKH
141 vistas12 diapositivas
Cell.pdfCell.pdf
Cell.pdfSwatiingle7
534 vistas32 diapositivas
Anatomy and Physiplogy.pptxAnatomy and Physiplogy.pptx
Anatomy and Physiplogy.pptxSwatiingle7
953 vistas35 diapositivas

Más contenido relacionado

La actualidad más candente

Bone pptBone ppt
Bone pptDr. Alim-Ul Azim
1.5K vistas22 diapositivas
Skeletal system pharmaSkeletal system pharma
Skeletal system pharmaLama K Banna
4.5K vistas91 diapositivas
1 introduction to anatomy1 introduction to anatomy
1 introduction to anatomyisakwisa willey
1.9K vistas36 diapositivas
human cell.ppthuman cell.ppt
human cell.pptVijay Salvekar
917 vistas56 diapositivas

La actualidad más candente(20)

Bone pptBone ppt
Bone ppt
Dr. Alim-Ul Azim1.5K vistas
Skeletal system pharmaSkeletal system pharma
Skeletal system pharma
Lama K Banna4.5K vistas
1 introduction to anatomy1 introduction to anatomy
1 introduction to anatomy
isakwisa willey1.9K vistas
Levels of structural organizationLevels of structural organization
Levels of structural organization
Devendra Rawat1.5K vistas
human cell.ppthuman cell.ppt
human cell.ppt
Vijay Salvekar917 vistas
BoneBone
Bone
Soneeshah296 vistas
Tissues of Human body.pdfTissues of Human body.pdf
Tissues of Human body.pdf
RAMDAS BHAT1.2K vistas
The human body an orientationThe human body an orientation
The human body an orientation
Abay Alem6.7K vistas
Scope of anatomy & physiologyScope of anatomy & physiology
Scope of anatomy & physiology
Devendra Rawat5.7K vistas
Skeletal systemSkeletal system
Skeletal system
nicolepriscillax1.3K vistas
Skeletal system Skeletal system
Skeletal system
Jai Narain Vyas University Jodhpur Rajasthan India 3420031.2K vistas
Cell and its Physiology.pdfCell and its Physiology.pdf
Cell and its Physiology.pdf
RAMDAS BHAT727 vistas
Introduction to human bodyIntroduction to human body
Introduction to human body
Yogeshwary Bhongade607 vistas
Lecture 1 (introduction to bone)Lecture 1 (introduction to bone)
Lecture 1 (introduction to bone)
Ayub Abdi1.4K vistas
Introduction to hapIntroduction to hap
Introduction to hap
deepaingawale219.2K vistas
Introduction to anatomy.pptxIntroduction to anatomy.pptx
Introduction to anatomy.pptx
mans4ani1.9K vistas
Human AnatomyHuman Anatomy
Human Anatomy
000 073.4K vistas
Muscle and its physiology.pdfMuscle and its physiology.pdf
Muscle and its physiology.pdf
RAMDAS BHAT335 vistas

Similar a Impurities in pharmaceuticals

IMPURITIESIMPURITIES
IMPURITIESPravinMuli
766 vistas21 diapositivas
Impurity (effect and sources)Impurity (effect and sources)
Impurity (effect and sources)TAUFIK MULLA
197 vistas16 diapositivas
class 4.pptxclass 4.pptx
class 4.pptxKomalJAIN122
2 vistas14 diapositivas

Similar a Impurities in pharmaceuticals(20)

IMPURITIESIMPURITIES
IMPURITIES
PravinMuli766 vistas
Impurity (effect and sources)Impurity (effect and sources)
Impurity (effect and sources)
TAUFIK MULLA197 vistas
Impurities in PharmaceuticalsImpurities in Pharmaceuticals
Impurities in Pharmaceuticals
Dr. Alex Martin459 vistas
class 4.pptxclass 4.pptx
class 4.pptx
KomalJAIN1222 vistas
ImpuritiesImpurities
Impurities
Dr.Lingeswararao Punati21.2K vistas
Sources and types of impuritiesSources and types of impurities
Sources and types of impurities
jagan vana6.6K vistas
Impurites Impurites
Impurites
shinganaarti540 vistas
Chemical based hazards wordChemical based hazards word
Chemical based hazards word
DhruviParmar5K vistas
Impurities and their limit testImpurities and their limit test
Impurities and their limit test
ESHA SHAH130.3K vistas
Safety in the laboratorySafety in the laboratory
Safety in the laboratory
Kirimi Mwobobia II26 vistas
HUKUM.pdfHUKUM.pdf
HUKUM.pdf
KushalSrivastava239 vistas
Hazardous Waste ManagementHazardous Waste Management
Hazardous Waste Management
Malla Reddy University58.5K vistas
QUALITY CONTROL AND QUALITRY ASSURANCEQUALITY CONTROL AND QUALITRY ASSURANCE
QUALITY CONTROL AND QUALITRY ASSURANCE
Sandip Mavchi789 vistas
Stock PollutantsStock Pollutants
Stock Pollutants
Avishek Das Gupta11 vistas

Más de P.N.DESHMUKH

General Anaesthesia General Anaesthesia
General Anaesthesia P.N.DESHMUKH
6 vistas8 diapositivas
sedative and hypnoticssedative and hypnotics
sedative and hypnoticsP.N.DESHMUKH
5 vistas10 diapositivas
Blood Centre(Bank)Blood Centre(Bank)
Blood Centre(Bank)P.N.DESHMUKH
77 vistas17 diapositivas
The poison act, 1919 The poison act, 1919
The poison act, 1919 P.N.DESHMUKH
52 vistas7 diapositivas

Más de P.N.DESHMUKH (9)

General Anaesthesia General Anaesthesia
General Anaesthesia
P.N.DESHMUKH 6 vistas
sedative and hypnoticssedative and hypnotics
sedative and hypnotics
P.N.DESHMUKH 5 vistas
Blood Centre(Bank)Blood Centre(Bank)
Blood Centre(Bank)
P.N.DESHMUKH 77 vistas
The poison act, 1919 The poison act, 1919
The poison act, 1919
P.N.DESHMUKH 52 vistas
Drugs and magic Remedies, Act 1954Drugs and magic Remedies, Act 1954
Drugs and magic Remedies, Act 1954
P.N.DESHMUKH 144 vistas
Chapter 1 (PHARMACY LAW AND ETHICS)Chapter 1 (PHARMACY LAW AND ETHICS)
Chapter 1 (PHARMACY LAW AND ETHICS)
P.N.DESHMUKH 371 vistas
Pharmacy Act,1948Pharmacy Act,1948
Pharmacy Act,1948
P.N.DESHMUKH 693 vistas

Último(20)

Case Study_ AI in the Life Sciences Industry.pptxCase Study_ AI in the Life Sciences Industry.pptx
Case Study_ AI in the Life Sciences Industry.pptx
Emily Kunka, MS, CCRP24 vistas
Pediatric ConstipationPediatric Constipation
Pediatric Constipation
DrArjunPawar41 vistas
Preparation and Evaluation Ointment.pptxPreparation and Evaluation Ointment.pptx
Preparation and Evaluation Ointment.pptx
Sudhanshu Sagar51 vistas
Cholera Romy W. (3).pptxCholera Romy W. (3).pptx
Cholera Romy W. (3).pptx
rweth6138 vistas
Common Surgical  conditions in kidsCommon Surgical  conditions in kids
Common Surgical conditions in kids
DrArjunPawar34 vistas
NMP-5.pptxNMP-5.pptx
NMP-5.pptx
Sai Sailesh Kumar Goothy19 vistas
Pathogenesis of Cell Injury.pptxPathogenesis of Cell Injury.pptx
Pathogenesis of Cell Injury.pptx
Systematic Learning52 vistas
 Fastest Growing Pharmaceutical Companies in India Fastest Growing Pharmaceutical Companies in India
Fastest Growing Pharmaceutical Companies in India
Unimarck Pharma India Ltd.32 vistas
Depression PPT templateDepression PPT template
Depression PPT template
EmanMegahed618 vistas
The AI apocalypse has been canceledThe AI apocalypse has been canceled
The AI apocalypse has been canceled
Tina Purnat104 vistas
Anaemia,jaundice.pptxAnaemia,jaundice.pptx
Anaemia,jaundice.pptx
Reena Gollapalli13 vistas
 CAPSULE CAPSULE
CAPSULE
Ganapathi Vankudoth57 vistas
ROSE CASE CARDIAC  ARRHYTHMIA SBRTROSE CASE CARDIAC  ARRHYTHMIA SBRT
ROSE CASE CARDIAC ARRHYTHMIA SBRT
Kanhu Charan31 vistas
Biopharmaceutics.pptxBiopharmaceutics.pptx
Biopharmaceutics.pptx
TsegayeNigussie510 vistas

Impurities in pharmaceuticals

  • 1. IMPURITIES IN PHARMACEUTICALS Prepared & presented By Priyanka Deshmukh K.Y.D.S.C.T’s college of pharmacy, sakegaon
  • 2. Impurity  Impurity is the undesirable foreign material which may be toxic or non toxic present in the pharmaceutical substance.  Impurity is the substance or the matter which does not form a part of the medicinal or pharmaceutical substance or drugs. Presentation Title 2
  • 3. 1. Raw materials used in the manufacturer. 2. Process used in the manufacturer. 3. Material of the plant. 4. Inadequate storage. 5. Accidental substitutions/deliberate adulteration with spurious/ useless substance. 6. Manufacturing hazards. Sources of impurities
  • 4. 1. Raw materials used in the manufacturer Traces of raw materials may come in the final product e.g. 1. Traces of some sodium compounds in sodium chloride or the traces of chloride.may be present in them if not prepared carefully. 2. Metallic zinc may be present as on impurity in zinc oxide sample as zinc oxide can be prepared by heating metallic zinc(raw materials) 2. Process used in the manufacture 1. Tap water is invariably used in various processes. This tap water contains chloride, calcium & magnesium, which may contaminate the substance which is to be manufactured. 2. Due to the wide use of strong acids in the manufacture of medicinal substances chloride & sulphate ions are very Commonly occuring impurities. 4
  • 5. Presentation Title 3. Material of the plant 4. Inadequate storage 1. The equipment or utensils used in the manufacturing processes are made of metals like copper, aluminium, iron, zinc, nickel. & tin or stainless steel. 2. Due to action of the solvents on the material of the equipment or utensils, traces of the equipment or utensils, traces of the metals are introduced as impurities in the compound 2. Decomposition of the product during storage Many chemical substances undergo changes decomposition due to careless storage. a) Due to careless storage, ferrous sulphate is slowly converted into Insoluble ferric oxide by air & moisture. b) Bismuth / carbonate blackens on long exposure to sunlight. 1. Filth: stored products may become contaminated with dust, the bodies of insects and even animal and insect excreta.
  • 6. Presentation Title 5. Accidental substitutions/deliberate adulteration with spurious/useless substance 1. Accidental substitution can take place if toxic substances are stocked with other substances or compound due to incomplete saponification there may be presence of alkali impurities. 2. Deliberate adulteration or substitution with cheaper drugs or varities is a possibility. e.g. a) Asafoetida can be adulterated with wheat, flour stones.. b) In honey, commerical sugar can be an adulterant. c) Acacia powder can be adulterated with clay
  • 7. Presentation Title 6. Manufacturing Hazards i) Particulate Contamination: Accidental inclusion of dirt or glass, porcelain, metallic or plastic fragments from sieves, granulating, tableting and filling machines or even from product containers, may come from either bulk material used in formulation or from improperly cleaned equipment or containers, but is more likely to be present due to wear and tear of equipment. ii) Process Errors: Gross errors arising from incomplete solution of a solute in a liquid preparation should probably be detected readily by normal analytical control procedures. iii) Cross Contamination: The handling of powders, granules and tablets in bulk quantities, frequently create a considerable amount of air-borne dust, which if not controlled, leads to cross contamination of products, particularly of steroidal and other synthetic hormones and antibiotics like penicillin.
  • 8. Presentation Title 6. Manufacturing Hazards (iv) Microbial Contamination: Liquid preparations and creams for topical application to broken skin or mucous membrane are liable to bacterial, mould and fungal contamination from the atmosphere. (v) Packing Errors: Products of similar appearance, such as tablets of same size, colour and shape packed in similar containers can cause danger through mislabelling.
  • 9. Effects of impurities in pharmacopoeial substance The impurities which produce toxic effect on body, if present beyond the prescribed limit, e.g. Lead and arsenic impurities. Impurities which are harmless but if present beyond a limit in pharmaceutical substance, lowers the active strength of that substance. e.g. Impurities of sodium salts in potassium salts. Impurities which, if present, beyond the limit, affect the storage capacity of the pharmaceuticals, e.g., Presence of moisture beyond limit, may activate the free flowing property of a substance or may decompose it. Impurities causing technical difficulties, while using the substance, in which it is present. e.g. Presence of carbonate impurity in the ammonia solution. Impurities such as taste, odour or colour or appearance which are easily detectable by the senses and make the substance unaesthetic or unhygienic, e.g. Phenolic impurities present in sodium salicylate, alter its colour. Traces of magnesium salts in sodium chloride render it damp and change its appearance